OncoPrint data analysis of prostate cancer patients further uncovers the possibilities of AQP1, AQP3, AQP5 and AQP9 being developed as prognostic biomarkers for prostate cancer (Figure 2). Here, AQP5 is linked to prostate carcinoma.